Wall Street brokerages expect Nutrien Ltd (NYSE:NTR) to announce $0.32 earnings per share for the current quarter, according to Zacks. Three analysts have provided estimates for Nutrien’s earnings, with the lowest EPS estimate coming in at $0.23 and the highest estimate coming in at $0.43. Nutrien posted earnings of $0.54 per share during the same quarter last year, which suggests a negative year over year growth rate of 40.7%. The firm is scheduled to announce its next quarterly earnings report on Wednesday, February 5th.
On average, analysts expect that Nutrien will report full year earnings of $2.48 per share for the current year, with EPS estimates ranging from $2.25 to $2.94. For the next financial year, analysts expect that the firm will report earnings of $3.18 per share, with EPS estimates ranging from $2.35 to $3.96. Zacks Investment Research’s earnings per share calculations are a mean average based on a survey of research firms that follow Nutrien.
Nutrien (NYSE:NTR) last posted its quarterly earnings data on Monday, November 4th. The company reported $0.24 earnings per share for the quarter, missing the consensus estimate of $0.36 by ($0.12). Nutrien had a return on equity of 6.49% and a net margin of 20.95%. The company had revenue of $4.13 billion during the quarter, compared to the consensus estimate of $4.02 billion. During the same quarter last year, the firm earned $0.47 EPS. The business’s revenue for the quarter was up 3.6% on a year-over-year basis.
Several institutional investors have recently modified their holdings of the business. Beutel Goodman & Co Ltd. raised its position in shares of Nutrien by 5.7% during the 2nd quarter. Beutel Goodman & Co Ltd. now owns 13,435,410 shares of the company’s stock valued at $718,661,000 after acquiring an additional 718,508 shares during the last quarter. Invesco Ltd. increased its position in shares of Nutrien by 0.7% in the 2nd quarter. Invesco Ltd. now owns 10,145,011 shares of the company’s stock valued at $542,352,000 after buying an additional 66,593 shares in the last quarter. Mackenzie Financial Corp increased its position in shares of Nutrien by 11.3% in the 2nd quarter. Mackenzie Financial Corp now owns 8,580,722 shares of the company’s stock valued at $458,725,000 after buying an additional 872,389 shares in the last quarter. Schroder Investment Management Group increased its position in shares of Nutrien by 1.4% in the 2nd quarter. Schroder Investment Management Group now owns 8,319,990 shares of the company’s stock valued at $552,612,000 after buying an additional 117,187 shares in the last quarter. Finally, Great West Life Assurance Co. Can increased its position in shares of Nutrien by 1.7% in the 3rd quarter. Great West Life Assurance Co. Can now owns 5,498,521 shares of the company’s stock valued at $274,841,000 after buying an additional 91,897 shares in the last quarter. Institutional investors own 65.00% of the company’s stock.
NTR stock traded up $0.41 during trading on Wednesday, hitting $46.65. The company had a trading volume of 1,015,440 shares, compared to its average volume of 1,497,916. The company has a quick ratio of 0.77, a current ratio of 1.28 and a debt-to-equity ratio of 0.41. The firm has a 50-day moving average price of $48.42 and a 200-day moving average price of $50.36. Nutrien has a 12 month low of $43.96 and a 12 month high of $56.00. The stock has a market cap of $27.17 billion, a price-to-earnings ratio of 17.34, a PEG ratio of 2.61 and a beta of 0.89.
Nutrien Ltd. produces and markets crop nutrients to agricultural, industrial, and feed customers worldwide. It operates in four segments: Retail, Potash, Nitrogen, and Phosphate and Sulfate. The company offers potash, nitrogen, phosphate, and sulfate products. It also distributes crop nutrients, crop protection products, seeds, and merchandise products through operating 1,700 retail locations.
Featured Article: How Buying a Call Option Works
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Nutrien Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutrien and related companies with MarketBeat.com's FREE daily email newsletter.